65 related articles for article (PubMed ID: 2515947)
1. Heterogeneity of human Fc epsilon RI-bearing cells.
Warner JA; MacGlashan DW; Lichtenstein LM
Ciba Found Symp; 1989; 147():230-41; discussion 241-53. PubMed ID: 2515947
[TBL] [Abstract][Full Text] [Related]
2. Protein L. A bacterial Ig-binding protein that activates human basophils and mast cells.
Patella V; Casolaro V; Björck L; Marone G
J Immunol; 1990 Nov; 145(9):3054-61. PubMed ID: 1698870
[TBL] [Abstract][Full Text] [Related]
3. Anaphylactic- and calcium-dependent generation of prostaglandin D2 (PGD2), thromboxane B2, and other cyclooxygenase products of arachidonic acid by dispersed human lung cells and relationship to histamine release.
Holgate ST; Burns GB; Robinson C; Church MK
J Immunol; 1984 Oct; 133(4):2138-44. PubMed ID: 6206153
[TBL] [Abstract][Full Text] [Related]
4. Protein kinase C modulates immunoglobulin E-mediated activation of human mast cells from lung and skin. I. Pharmacologic inhibition.
Massey WA; Cohan VL; MacGlashan DW; Gittlen SW; Kagey-Sobotka A; Lichtenstein LM; Warner JA
J Pharmacol Exp Ther; 1991 Sep; 258(3):824-9. PubMed ID: 1716311
[TBL] [Abstract][Full Text] [Related]
5. IgE-mediated triggering signals for mediator release from human mast cells and basophils.
Ishizaka T; Conrad DH; Schulman ES; Sterk AR; Ko CG; Ishizaka K
Fed Proc; 1984 Oct; 43(13):2840-5. PubMed ID: 6207053
[TBL] [Abstract][Full Text] [Related]
6. Quantitation of tryptase, chymase, Fc epsilon RI alpha, and Fc epsilon RI gamma mRNAs in human mast cells and basophils by competitive reverse transcription-polymerase chain reaction.
Xia HZ; Kepley CL; Sakai K; Chelliah J; Irani AM; Schwartz LB
J Immunol; 1995 May; 154(10):5472-80. PubMed ID: 7730649
[TBL] [Abstract][Full Text] [Related]
7. Regulation of mast-cell and basophil function and survival by IgE.
Kawakami T; Galli SJ
Nat Rev Immunol; 2002 Oct; 2(10):773-86. PubMed ID: 12360215
[TBL] [Abstract][Full Text] [Related]
8. Regulation of high-affinity IgE receptor-mediated mast cell activation by murine low-affinity IgG receptors.
Daëron M; Malbec O; Latour S; Arock M; Fridman WH
J Clin Invest; 1995 Feb; 95(2):577-85. PubMed ID: 7860741
[TBL] [Abstract][Full Text] [Related]
9. The mast cell binding site on human immunoglobulin E.
Helm B; Marsh P; Vercelli D; Padlan E; Gould H; Geha R
Nature; 1988 Jan; 331(6152):180-3. PubMed ID: 3123993
[TBL] [Abstract][Full Text] [Related]
10. Human heart mast cells. Isolation, purification, ultrastructure, and immunologic characterization.
Patella V; Marinò I; Lampärter B; Arbustini E; Adt M; Marone G
J Immunol; 1995 Mar; 154(6):2855-65. PubMed ID: 7533185
[TBL] [Abstract][Full Text] [Related]
11. Proximal signaling events in Fc epsilon RI-mediated mast cell activation.
Kambayashi T; Koretzky GA
J Allergy Clin Immunol; 2007 Mar; 119(3):544-52; quiz 553-4. PubMed ID: 17336609
[TBL] [Abstract][Full Text] [Related]
12. Functional analysis of histamine release from basophils and mast cells in subjects with the Ile-181-->Leu variant of Fc epsilon RI-beta.
Li A; Mackay GA; Hopkin JM
Clin Sci (Lond); 1997 Sep; 93(3):279-86. PubMed ID: 9337644
[TBL] [Abstract][Full Text] [Related]
13. Oscillations in free cytosolic calcium during IgE-mediated stimulation distinguish human basophils from human mast cells.
MacGlashan D; Guo CB
J Immunol; 1991 Oct; 147(7):2259-69. PubMed ID: 1918962
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneity of human Fc epsilon RI-bearing cells.
Triggiani M; Casolaro V; Genovese A; Spadaro G; Marone G
Ann Allergy; 1993 Aug; 71(2):133-8. PubMed ID: 8346866
[TBL] [Abstract][Full Text] [Related]
15. CGP 41251, a novel protein kinase inhibitor with in vitro selectivity for protein kinase C, strongly inhibits immunological activation of human skin mast cells and human basophils.
Amon U; von Stebut E; Subramanian N; Wolff HH
Pharmacology; 1993 Sep; 47(3):200-8. PubMed ID: 7692457
[TBL] [Abstract][Full Text] [Related]
16. Co-cultivation of mast cells and Fc epsilon RI alpha+ dendritic-like cells from human hip bone marrow.
Kaur D; Berger P; Duffy SM; Brightling CE; Bradding P
Clin Exp Allergy; 2005 Feb; 35(2):226-33. PubMed ID: 15725196
[TBL] [Abstract][Full Text] [Related]
17. Semi-purification of the immunoglobulin E-sweat antigen acting on mast cells and basophils in atopic dermatitis.
Tanaka A; Tanaka T; Suzuki H; Ishii K; Kameyoshi Y; Hide M
Exp Dermatol; 2006 Apr; 15(4):283-90. PubMed ID: 16512875
[TBL] [Abstract][Full Text] [Related]
18. Chimeric immunoglobulin E reactive with tumor-associated antigen activates human Fc epsilon RI bearing cells.
Luiten RM; Warnaar SO; Schuurman J; Pasmans SG; Latour S; Daëron M; Fleuren GJ; Litvinov SV
Hum Antibodies; 1997; 8(4):169-80. PubMed ID: 9395919
[TBL] [Abstract][Full Text] [Related]
19. Purified human basophils and mast cells: current concepts of mediator release.
Schulman ES; MacGlashan DW; Schleimer RP; Peters SP; Kagey-Sobotka A; Newball HH; Lichtenstein LM
Eur J Respir Dis Suppl; 1983; 128 (Pt 1)():53-61. PubMed ID: 6578086
[TBL] [Abstract][Full Text] [Related]
20. The ascomycin macrolactam pimecrolimus (Elidel, SDZ ASM 981) is a potent inhibitor of mediator release from human dermal mast cells and peripheral blood basophils.
Zuberbier T; Chong SU; Grunow K; Guhl S; Welker P; Grassberger M; Henz BM
J Allergy Clin Immunol; 2001 Aug; 108(2):275-80. PubMed ID: 11496246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
